Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies

Category

Published in:

Frontiers in Pharmacology  
Vol. 15 (15.01.2024)

Volume:

15

Date Issued:

15.01.2024

DOI:

10.3389/fphar.2024.1365927

Language:

English

Type of Resource:

Text

Keywords:

1. tigecycline

   Typ

   Schlagwort

1. cefoperazone/sulbactam

   Typ

   Schlagwort

1. carbapenems

   Typ

   Schlagwort

1. β-lactam antibiotics

   Typ

   Schlagwort

1. coagulation disorders

   Typ

   Schlagwort

1. hypofibrinogenaemia

   Typ

   Schlagwort

DDC:

610 Medizin und Gesundheit